[1]
N. M. AL Hafidh, “EFFICACY OF INTERRUPTED AND MODIFIED DEFERASIROX DOSE AMONG PAEDIATRIC PATIENTS WITH Î’- THALASSEMIA MAJOR AND HIGH ALANINE AMINOTRANSFERASE LEVEL”, J Ayub Med Coll Abbottabad, vol. 31, no. 2, pp. 182–184, Mar. 2019.